Tekla Capital Management LLC Cidara Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.85 - $4.1 $556,479 - $800,549	-195,256 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.74 - $4.26 $63,461 - $155,370	36,472 Added 22.97%	195,256 $484,000
Q1 2018 May 14, 2018	SELL	$4.0 - $8.15 $510,752 - $1.04 Million	-127,688 Reduced 44.57%	158,784 $635,000
Q2 2017 Aug 14, 2017	BUY	N/A	286,472	286,472 $2.15 Million

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $753M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.